top of page

Astrocytoma

Vijay Padul

Sr. scientist – Omics

March 15, 2023

Summary "Multi-omic analysis of low-grade glioma histological subtypes uncovers the significance of tumor purity."

Astrocytoma and Oligodendroglioma are the histological subtypes of glioma brain tumors. Histological classification of gliomas has been the clinical practice before the inclusion of molecular markers by the...

Astrocytoma
Nupur Biswas

Sr. scientist - Omics

March 01, 2023

Summary "Circular RNAs in diagnosis of astrocytoma."

Astrocytoma is a type of brain tumor associated with astrocytes. Grade IV astrocytoma is commonly known as glioblastoma. Molecular-based diagnosis is challenging as it requires brain surgery for obtaining...

Circular RNAs in Diagnosis of Astrocytoma
Bharati Chundi

Content writer – Clinical

February 15, 2023

Summary "Expression of CD133 cancer stems cell marker in IDH-mutant and IDH-wild type (isocitrate dehydrogenase) astrocytoma."

Astrocytoma is a tumor that arises from the astrocytes. They belong to a group called glial cells, the supporting cells seen in the central nervous system. They are specifically called astrocytes when they are...

Expression of CD133 cancer stem cell marker in IDH-mutant and IDH-wild type (isocitrate dehydrogenase) astrocytoma.
Divyalakshmi

Content writer – Clinical

February 08, 2023

Summary "Prognostic factors associated with survival in patients with diffuse astrocytoma."

Astrocytomas are the most common primary tumors in the central nervous system (CNS). These tumors arise from astrocytes—star-shaped cells that make up the “glue-like” or supportive tissue of the brain. The diagnosis is based...

Prognostic factors associated with survival in patients with diffuse astrocytoma.
Numair Arshad

Content writer – Clinical

February 01, 2023

Summary "Exploring the safety and efficacy of a novel drug combination for treating recurrent high-grade astrocytomas: A phase 1 clinical trial."

Astrocytoma is a type of brain tumor that originates from star-shaped glial cells in the brain called astrocytes. According to the WHO classification, they are classified into four grades based on the degree of malignancy and...

Exploring the safety and efficacy of a novel drug combination for treating recurrent high-grade astrocytomas: A phase 1 clinical trial.
Yogita Dhas

Content writer – Clinical

January 17, 2023

Summary "Grading of IDH‑mutant astrocytoma using diffusion, susceptibility, and perfusion‑weighted imaging."

The accurate grading of IDH-mutant astrocytoma is essential to develop therapeutic strategies and evaluating the prognosis of patients. A preoperative classification of these entities could be beneficial for the treatments...

Grading of IDH‑mutant astrocytoma using diffusion, susceptibility, and perfusion‑weighted imaging
Background_edited_edited.jpg

Get the latest updates

Join Cell talk!

Subscribe to us today and receive the latest updates in your mailbox!

bottom of page